About 4 results found for searched term "Linezolid" (0.121 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1924 | Linezolid | Antibiotic |
| PNU-100766 | ||
| Linezolid (PNU-100766) is a synthetic antibiotic. Linezolid acts by inhibiting the initiation of bacterial protein synthesis. | ||
| M30778 | (R)-Linezolid | Metabolite/Endogenous Metabolite |
| (R)-PNU-100766 | ||
| (R)-Linezolid is an impurity of Linezolid (PNU-100766). Linezolid, the first member of the class of oxazolidinone synthetic antibiotic, acts by inhibiting the initiation of bacterial protein synthesis. | ||
| M24753 | Suvratoxumab | Anti-infection |
| MEDI4893 | ||
| Suvratoxumab (MEDI4893) is a long-acting, high-affinity humanized anti-α-toxin monoclonal antibody (IgG1κ type). Suvratoxumab potently neutralizes α-toxin, a key S. aureus virulence factor. Suvratoxumab improves survival and reduces lung injury in an immunocompromised mice model of pneumonia. Suvratoxumab also enhances the antibacterial activity of Vancomycin or Linezolid . | ||
| M30762 | Radezolid | Antibiotic |
| RX-1741 | ||
| Radezolid (RX-1741) is a oxazolidinone antibiotic. Radezolid is active against Staphylococcus, Chlamydia, and Legionella species, and remains active against Linezolid-resistant strains. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
